Egerton Capital UK LLP Increases Position in Arch Capital Group Ltd. (NASDAQ:ACGL)

Egerton Capital UK LLP increased its stake in Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 25.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,987,972 shares of the insurance provider's stock after purchasing an additional 816,750 shares during the period. Arch Capital Group accounts for 4.3% of Egerton Capital UK LLP's portfolio, making the stock its 10th largest position. Egerton Capital UK LLP owned approximately 1.06% of Arch Capital Group worth $368,289,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. State Street Corp lifted its holdings in shares of Arch Capital Group by 1.1% in the third quarter. State Street Corp now owns 16,587,446 shares of the insurance provider's stock valued at $1,855,803,000 after buying an additional 172,628 shares during the period. Geode Capital Management LLC raised its position in Arch Capital Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 10,830,263 shares of the insurance provider's stock valued at $1,208,307,000 after buying an additional 253,648 shares during the period. Principal Financial Group Inc. raised its position in Arch Capital Group by 10.5% during the fourth quarter. Principal Financial Group Inc. now owns 8,222,244 shares of the insurance provider's stock valued at $759,324,000 after buying an additional 783,506 shares during the period. Allspring Global Investments Holdings LLC raised its position in Arch Capital Group by 4.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 5,350,868 shares of the insurance provider's stock valued at $488,992,000 after buying an additional 226,617 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Arch Capital Group by 245.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,053,739 shares of the insurance provider's stock valued at $341,652,000 after buying an additional 2,168,897 shares during the period. Institutional investors own 89.07% of the company's stock.

Insider Transactions at Arch Capital Group

In other news, insider Louis T. Petrillo sold 11,600 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $91.00, for a total value of $1,055,600.00. Following the transaction, the insider now directly owns 140,023 shares in the company, valued at $12,742,093. This trade represents a 7.65 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.20% of the stock is owned by corporate insiders.

Arch Capital Group Stock Down 0.7 %

NASDAQ ACGL opened at $90.09 on Wednesday. The stock has a fifty day moving average of $91.89 and a 200-day moving average of $99.77. The stock has a market capitalization of $33.82 billion, a P/E ratio of 8.04, a price-to-earnings-growth ratio of 2.31 and a beta of 0.62. Arch Capital Group Ltd. has a 52 week low of $87.42 and a 52 week high of $116.47. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.58 and a current ratio of 0.54.

Remove Ads

Arch Capital Group (NASDAQ:ACGL - Get Free Report) last released its earnings results on Monday, February 10th. The insurance provider reported $2.26 EPS for the quarter, beating the consensus estimate of $1.90 by $0.36. Arch Capital Group had a return on equity of 17.96% and a net margin of 24.73%. During the same period in the previous year, the company posted $2.45 earnings per share. On average, equities research analysts forecast that Arch Capital Group Ltd. will post 8.42 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ACGL shares. Bank of America dropped their target price on Arch Capital Group from $143.00 to $136.00 and set a "buy" rating on the stock in a research report on Friday, November 15th. UBS Group decreased their target price on Arch Capital Group from $131.00 to $127.00 and set a "buy" rating for the company in a research note on Tuesday, February 18th. Wells Fargo & Company decreased their target price on Arch Capital Group from $107.00 to $106.00 and set an "overweight" rating for the company in a research note on Wednesday, February 12th. Morgan Stanley reduced their price objective on Arch Capital Group from $115.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. Finally, Barclays reduced their price objective on Arch Capital Group from $120.00 to $100.00 and set an "equal weight" rating for the company in a research report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $117.19.

Arch Capital Group Company Profile

Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile and inland marine products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.